UNLABELLED: Alterations of free fatty acid (FA) metabolism in several organs are implicated in the pathogenesis of chronic disorders. The aim of this study was to investigate the biodistribution and partitioning of the FA analog, 14(R,S)-(18)F-fluoro-6-thia-heptadecanoic acid ((18)F-FTHA), across different lipid pools in plasma and in metabolically important organs and its response to insulin. METHODS: Eight anesthetized pigs were studied during fasting or euglycemic insulin stimulation. Plasma samples from the carotid artery, hepatic vein, and portal vein were collected at 10 and 40 min after (18)F-FTHA injection via indwelling catheters. The animals were then sacrificed and tissue biopsies rapidly obtained from the heart, brain, liver, subcutaneous and visceral fat, pancreas, intestine, and skeletal muscle. Radioactivity was assessed in the FA, phospholipid, and triglyceride or glycerol ester pools. RESULTS: The tissue-to-plasma intact (18)F-FTHA ratio was high in all tissues, with the highest values being in the heart and liver; (18)F-FTHA accumulated in the brain to a significant extent. Hyperinsulinemia was associated with higher plasma (18)F-FTHA clearance (P < 0.05) and lower labeled triglyceride appearance (P <or= 0.01) than those associated with fasting, indicating faster tissue removal and suppressed hepatic triglyceride release. Tracer retention was enhanced in skeletal muscle, pancreas, and visceral fat (P < 0.05 vs. fasting). Under both study conditions, tissue radioactivity was greatly accounted for by glycerol ester. CONCLUSION: (18)F-FTHA is a promising tracer in PET imaging of metabolically important organs, which are currently inaccessible in vivo. Physiologic hyperinsulinemia enhances plasma tracer clearance in fat, skeletal muscle, and pancreas.
UNLABELLED: Alterations of free fatty acid (FA) metabolism in several organs are implicated in the pathogenesis of chronic disorders. The aim of this study was to investigate the biodistribution and partitioning of the FA analog, 14(R,S)-(18)F-fluoro-6-thia-heptadecanoic acid ((18)F-FTHA), across different lipid pools in plasma and in metabolically important organs and its response to insulin. METHODS: Eight anesthetized pigs were studied during fasting or euglycemic insulin stimulation. Plasma samples from the carotid artery, hepatic vein, and portal vein were collected at 10 and 40 min after (18)F-FTHA injection via indwelling catheters. The animals were then sacrificed and tissue biopsies rapidly obtained from the heart, brain, liver, subcutaneous and visceral fat, pancreas, intestine, and skeletal muscle. Radioactivity was assessed in the FA, phospholipid, and triglyceride or glycerol ester pools. RESULTS: The tissue-to-plasma intact (18)F-FTHA ratio was high in all tissues, with the highest values being in the heart and liver; (18)F-FTHA accumulated in the brain to a significant extent. Hyperinsulinemia was associated with higher plasma (18)F-FTHA clearance (P < 0.05) and lower labeled triglyceride appearance (P <or= 0.01) than those associated with fasting, indicating faster tissue removal and suppressed hepatic triglyceride release. Tracer retention was enhanced in skeletal muscle, pancreas, and visceral fat (P < 0.05 vs. fasting). Under both study conditions, tissue radioactivity was greatly accounted for by glycerol ester. CONCLUSION: (18)F-FTHA is a promising tracer in PET imaging of metabolically important organs, which are currently inaccessible in vivo. Physiologic hyperinsulinemia enhances plasma tracer clearance in fat, skeletal muscle, and pancreas.
Authors: Sanna M Honkala; Jarkko Johansson; Kumail K Motiani; Jari-Joonas Eskelinen; Kirsi A Virtanen; Eliisa Löyttyniemi; Juhani Knuuti; Pirjo Nuutila; Kari K Kalliokoski; Jarna C Hannukainen Journal: J Cereb Blood Flow Metab Date: 2017-09-29 Impact factor: 6.200
Authors: Fang Zhang; Guiyang Hao; Mengle Shao; Kien Nham; Yu An; Qiong Wang; Yi Zhu; Christine M Kusminski; Gedaa Hassan; Rana K Gupta; Qiwei Zhai; Xiankai Sun; Philipp E Scherer; Orhan K Oz Journal: Cell Metab Date: 2018-01-09 Impact factor: 27.287
Authors: Elizabeth M Rhea; Therese S Salameh; Aric F Logsdon; Angela J Hanson; Michelle A Erickson; William A Banks Journal: AAPS J Date: 2017-04-10 Impact factor: 4.009
Authors: Ayon Ibrahim; Michael D Neinast; Kristina Li; Michael Noji; Boa Kim; Marc R Bornstein; Raffiu Mohammed; Kathryn E Wellen; Zoltan Arany Journal: J Cell Sci Date: 2021-12-16 Impact factor: 5.285
Authors: Anna Karmi; Patricia Iozzo; Antti Viljanen; Jussi Hirvonen; Barbara A Fielding; Kirsi Virtanen; Vesa Oikonen; Jukka Kemppainen; Tapio Viljanen; Letizia Guiducci; Merja Haaparanta-Solin; Kjell Någren; Olof Solin; Pirjo Nuutila Journal: Diabetes Date: 2010-06-21 Impact factor: 9.461
Authors: Antje Bruckbauer; Michael B Zemel; Teresa Thorpe; Murthy R Akula; Alan C Stuckey; Dustin Osborne; Emily B Martin; Stephen Kennel; Jonathan S Wall Journal: Nutr Metab (Lond) Date: 2012-08-22 Impact factor: 4.169